Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrial contact site and cristae organizing system subunit 10 (MICOS10), also known as MIC10, is a critical component of the MICOS complex, a multi-protein assembly located at the inner membrane of mitochondria where it orchestrates the formation and maintenance of crista junctions and overall mitochondrial architecture[1][5]. MICOS10 plays a vital role in enabling proper mitochondrial respiration by preserving the structural integrity of cristae, which are essential for efficient energy production[2][3][5]. Genetic variants in MICOS10 have been identified as a cause of hepatocerebral mitochondrial DNA depletion syndrome (MTDPS), a severe disorder featuring liver and central nervous system involvement due to impaired mitochondrial structure and function[1][2][3]. Current evidence implicates MICOS10 as necessary for normal mitochondrial DNA maintenance and suggests that deficiency disrupts mitochondrial dynamics, reduces ATP synthesis, and impairs organ function, but it is not a direct therapeutic target—no drugs are known to interact with or modulate MICOS10 directly[1][2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial contact site and cristae organizing system subunit 10 (MICOS10).